The data were analyzed by standard methods of statistical analysis. Unless stated otherwise, the levels of significance of the differences reported in tables and text were calculated by the Student t test for paired variates.
RESULTS
E$ect of glucagon infusion on plasma FFA and blood sugar in geese. The mean FFA and blood sugar levels of groups of 1407 geese infused for 2 hr with different doses of glucagon and with glycinc buffer (controls), expressed as percent of the corresponding preinfusion levels, are presented in Fig. 1 . With the exception of the dose of 0.01 pg/kg per min, all the other doses caused a prompt elevation of plasma FFA reaching, at between 15 and 30 min, a level that remained almost constant until the end of the infusion period. Plasma FFA showed a marked decrease 30 min after discontinuing the glucagon infusion. No significant changes of plasma FFA were observed in the control geese infused with glycine buffer.
For the doses between 0.05 and 0.5 pg/kg per min, the effect of glucagon measured by the area of the curve of FFA concentration above the preinfusion level showed a positive correlation with the logarithm of the glucagoninfusion rate (r for 22 geese = +0.74, P < 0.01). Glucagon infusion at the rates of 0.05-0.5 pg/kg per min caused a progressive elevation of blood sugar throughout the ininfusion period. The doses of 0.1, 0.2, and 0.5 pg/kg per min caused blood sugar levels significantly higher than the preinfusion value (P < 0.01). (SE + 25.6 ) at 120 min of infusion significant (P = 0.18). On the other hand, the blood sugar (P = 0.02). lJo significant blood sugar changes were oblevel as 120 min was higher by 91 mg/lOO ml (SE =t 11.7) served in the control geese infused with glycine buffer or in than that at 30 min, and this difference was significant those infused with glucagon at the rate of 0.01 ,ug/kg per (P = 0.0003). No significant change of FFA or blood sugar min.
was observed in the control ducks infused with glycine Similar results were obtained with longer infusion periods.
buffer. The data are summarized in Table 1 The doses of end of infusion. Four control geese infused with glycine 0.1, 0.2, and 0.5 pg/kg per min caused a progressive elevabuffer showed no elevation of the lipid content of the liver. tion of plasma TGL, but no differences were found among Plasrna FFA of the control geese were 1.03 (SE & 0.06) bethese doses with respect to their effect on the serum TGL fore infusion and 1.0 (SE & 0.06) at the end of infusion. levels. Figure 2 summarizes the results. The total lipid content of the liver of six ducks infused for Plasma TGL values were higher 30 min after the end of 1 hr with 1.0 hg/kg per min of glucagon was 8.07 % infusion than at the end of infusion. Data are available for (SE & 0.38) . That of five control ducks infused with glycine 10 geese infused with 0.5 (three animals), 0.2 (one animal), buffer was 6.32 % (SE & 0.17) . The difference between these and 0.1 (six animals) pg/kg per min. The mean difference means (1.75, SE zt 0.42) was significant (P = 0.002, between the TGL levels at 150 min and those at 120 min t test for nonpaired variates). Plasma FFA levels are reported (end of infusion) was 33 mg/lOO ml (SE =t 7.2, P = 0.0015).
in Table 1 . Glucagon infusion in ducks. Plasma FFA were significantly Changes of liver lipid fractions in glucagon infused ducks. elevated 30 min after the beginning of infusion with 0.5 Table 2 summarizes the results obtained in six mallard male pg/kg per min of glucagon.
The mean FFA level at 120 ducks infused for 2 hr with 0.5 pug of glucagon/kg per min min of infusion was higher by 0.40 mEq/liter (SE zt and in six control ducks infused with glycine buffer. Glu-0.28) than that at 30 min, but this difference was not cagon caused a marked and statistically significant eleva- Table  1 . Two other groups of mallard male ducks received infusions of 0.5 pg/kg per min of either epinephrine or norepinephrine.
The results of these experiments are presented in Table 3 . No significant change of TGL was produced by either of the two catecholamines.
Norepinephrine produced a small but significant decrease of phospholipids and cholesterol.
The plasma FFA decreased during the infusion with catecholamines.
The mean decrease from the preinfusion level (mEq/liter) was 0.62 (SE =t 0.12) for the six ducks receiving epinephrine and 0.74 (SE =t 0.19) for the six ducks receiving norepinephrine. Both decreases were significant (P < 0.01).
Fatty acid composition of the liver lipid. The lipid extracts from liver samples taken before and at the end of the infusion periods in the experiments on ducks reported in Tables 2 and 3 were analyzed for fatty acids by gas-liquid chromatography.
Samples of abdominal adipose tissue from the control animals (infused with glycine buffer) were also analyzed.
The four fatty acids palmitic (C&, stearic (C~IJ:~), oleic (C&r), and linoleic (C1& accounted for 95 % or more of the total fatty acids of the liver lipid and of the adipose tissue lipid. Mean percentages of these four fatty acids in the lipids extracted from the liver before and after the infusions of glucagon, epinephrine, and norepinephrine are given in Fig. 3 . Mean values for the adipose tissue are included with the data of the glucagon-infused ducks.
Glucagon infusion caused no significant change in the content of C l&O or Cr8:2 of the liver lipid (P > 0.05), but the content of C lgZo showed a mean decrease of 12.3% (sfsO.53) at the end of the infusion period and that of Cr8:r showed a mean increase of 7.7% Q11.51). Both changes were statistically significant (P < O.Ol), indicating that the lipid deposited during the infusion of glucagon was lower in stearic acid and higher in oleic acid that the lipid originally present in the liver. Fig. 3 shows that the adipose tissue lipid was also lower in stearic and higher in oleic acid than the liver lipid, but the content of the adipose tissue lipid in palmitic and linoleic acids was not significantly different from that of the liver lipid before or after the infusion.
No significant changes of fatty acid distribution were produced by the infusion of epinephrine or norepinephrine.
DISCUSSION
For infusion rates between 0.05 and 0.5 pg/kg per min, the effect of glucagon on plasma FFA concentration showed a positive correlation with the logarithm of the infusion rate. A similar correlation was found between the FFA effect and the logarithm of the dose of glucagon given as a single intravenous injection in geese (22). The plasma FFA level was maintained practically constant between 15 and 30 min and the end of the infusion indicating that the rates of FFA release from the adipose tissue and FFA removal from the blood must have been equal during this period. The rate of FFA removal depends on their plasma concentration (14, 18, 30, 33) or, more specifically, on the molar ratio of plasma FFA to albumin (48). The fact that increasing rates of glucagon infusion produced higher plateau levels of plasma FFA indicates therefore that the rate of FFA release from adipose tissue increased with the rate of glucagon infusion.
Glucagon infusion caused marked elevations of blood sugar, but the blood sugar levels rose continuously throughout the infusion period suggesting that glucose utilization did not keep pact with the increased influx of glucose into the blood produced by glucagon. Whether there was an actual reduction of glucose utilization because of the high lcvcls of plasma FFA cannot be decided with our data, but such a possibility is supported by a number of reports in the literature (41, 44, 46 (12, 29, 47) . It is currently considered that the rate of mobilization of FFA from the adipose tissue is an important factor in controlling the rate of release of lipoproteins by the liver (6, 17, 19, 25, 34, 35, 37, 49) that, for the same level of plasma FFA, the liver of the glucagon-infused duck deposited TGL faster than the liver of the norepinephrine-treated dog. Indeed, the deposition of TGL in the liver of ducks infused with glucagon occurred with remarkable speed. In one duck infused with 3.0 pg/kg per min of glucagon, the liver TGL level rose from 14.7 to 52.3 mg/g after 30 min of infusion.
The total increase of liver TGL for the ducks reported in Table 2 averaged 575 mg per duck. The average amount of glucagon infused per duck was 64 pg. Therefore the infusion of 1 .O I,cg of glucagon was associated with an increase of 9.0 mg in the TGL content of the liver. Since the molecular weight of glucagon is 4.2 times that of an average triglyceride, it may be calculated that the TGL content of the liver increased by some 38,000 molecules for each molecule of glucagon infused. Studies on the distribution of injected palmitate-l-14C indicate that, in the rat liver, lipids account for about 30 % of the total radioactivity recovered from the body (4, 3 1, 38 ). Assuming that these data are valid for the glucagon-infused duck, it may be estimated that the total amount of FFA liberated under the influence of glucagon was 3 times that found as excess triglyceride in the liver. There is much evidence indicating that the deposition of liver TGL associated with the administration of adipokinetic hormones is the direct result of increased uptake of FFA by the liver induced by the elevated plasma FFA concentration (2, 7, 9, 10, 15, 19, 32, 37) . Our results are in good agreement with these observations : glucagon caused elevations of plasma FFA and deposition of fat in the liver of geese and ducks, whereas epinephrine and norepinephrine produced neither elevation of plasma FFA nor increase of liver TGL in the duck, by contrast to their effects in mammals.
The changes in fatty acid composition of the liver lipid observed in the glucagon-infused ducks are consistent with the view that the fa tty acids deposi transported from the adi .pose tissue.
.ted in the liver were 
